BD Commences Offerings of $4.5B of Common Stock, Depositary Shares

May 08, 2017

|

NEW YORK (GenomeWeb) – Becton Dickinson today said it has commenced registered offerings of $2.25 billion of common stock and $2.25 billion of depositary shares.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

BD Commences Offerings of $4.5B of Common Stock, Depositary Shares

To read the full story....

Breaking News

CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

Agendia Settles Allegations of Medicare Fraud for $8.25M

Noridian Aligns With Palmetto on Single-Gene, Multi-Gene PGx Test Coverage

Demand for SARS-CoV-2 Diagnostic Tests Drives Sharp Increase in 360Dx Index for First Half of 2020

Sysmex Nabs Japan Approval for Automated Hematology Analyzer to Diagnose Malaria

Centogene Gets Emergency Use Authorization for PCR-Based Coronavirus Test

What's Popular?

Demand for SARS-CoV-2 Diagnostic Tests Drives Sharp Increase in 360Dx Index for First Half of 2020

FDA Grants EUAs for PCR Coronavirus Tests, Nasal Swab Self-Collection Kit

Sherlock Biosciences, Binx Health Partner to Develop CRISPR-Based POC COVID-19 Test

NanoDiagnostics Closes $18M Series C Round

FDA Issues Warning Letter to Luminex

Sponsorships